Načítá se...
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)
INTRODUCTION: Anticoagulation without bleeding is an ideal goal in treating thrombosis, however, this goal has not been achieved. All current anticoagulants are associated with significant bleeding which limits their safe use. Genetic and pharmacological findings indicate that factor XIa is a key pl...
Uloženo v:
| Vydáno v: | Expert Opin Ther Pat |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515655/ https://ncbi.nlm.nih.gov/pubmed/31847619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2020.1705783 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|